Table 2 The association between AMPK and all clinico-pathological and immunohistochemical data
From: Histological evaluation of AMPK signalling in primary breast cancer
| Â | Â | Cohort 1 | Cohort 2 | ||||
|---|---|---|---|---|---|---|---|
Parameter | Â | Positive | Negative | P | Positive | Negative | P |
HER2 | Positive | 0 | 14 | NS | 0 | 13 | NS |
| Â | Negative | 12 | 87 | Â | 3 | 95 | Â |
Ki67 | Positive | 4 | 36 | NS | 7 | 95 | NS |
| Â | Negative | 8 | 65 | Â | 11 | 111 | Â |
ACC | Positive | 7 | 20 | 0.007 | 7 | 29 | 0.014 |
| Â | Negative | 5 | 81 | Â | 12 | 186 | Â |
ERα | Positive | 9 | 61 | NS | 12 | 157 | NS |
| Â | Negative | 3 | 38 | Â | 7 | 59 | Â |
Tumour size (cm) | ≤ 2 | 7 | 51 | NS | 9 | 79 | NS |
| Â | > 2 | 2 | 43 | Â | 10 | 138 | Â |
Positive axillary nodes | 0 | 8 | 39 | 0.021 | 15 | 111 | 0.087 |
| Â | 1-3 | 2 | 44 | Â | 2 | 71 | Â |
| Â | > 3 | 0 | 12 | Â | 2 | 35 | Â |
Histological grade | 1 | 5 | 7 | 0.010 | 6 | 57 | 0.021 |
| Â | 2 | 2 | 39 | Â | 7 | 81 | Â |
| Â | 3 | 4 | 53 | Â | 5 | 99 | Â |
KM overall survival | Alive | 11 | 73 | NS | 11 | 154 | NS |
| Â | Dead | 1 | 28 | Â | 4 | 35 | Â |